Jean-Marc Bellemin
Chief Financial Officer
CFO
Executive changes
-
Resigned Chief Financial Officer and principal financial and accounting officer at Iovance Biotherapeutics, Inc. (IOVA)2025-07-10
Earnings-call appearances
-
Iovance Biotherapeutics, Inc. Q1 FY2025 Earnings Call2025-05-08
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q4 FY2024 Earnings Call2025-02-27
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q3 FY2024 Earnings Call2024-11-07
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q2 FY2024 Earnings Call2024-08-08
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q1 FY2024 Earnings Call2024-05-09
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q4 FY2023 Earnings Call2024-02-28
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q3 FY2023 Earnings Call2023-11-07
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q2 FY2023 Earnings Call2023-08-08
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q1 FY2023 Earnings Call2023-05-09
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q4 FY2022 Earnings Call2023-02-28
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q3 FY2022 Earnings Call2022-11-03
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q2 FY2022 Earnings Call2022-08-04
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q1 FY2022 Earnings Call2022-05-05
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q4 FY2021 Earnings Call2022-02-24
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q3 FY2021 Earnings Call2021-11-04
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q2 FY2021 Earnings Call2021-08-05
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q1 FY2021 Earnings Call2021-05-06
Iovance Biotherapeutics, Inc. (IOVA)
-
Iovance Biotherapeutics, Inc. Q4 FY2020 Earnings Call2021-02-25
Iovance Biotherapeutics, Inc. (IOVA)